Gilder Gagnon Howe & Co’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-333,176
| Closed | -$43.8M | – | 419 |
|
|
2020
Q4 | $43.8M | Sell |
333,176
-2,173
| -0.6% | -$286K | 0.22% | 109 |
|
|
2020
Q3 | $16.9M | Sell |
335,349
-8,640
| -3% | -$437K | 0.1% | 144 |
|
|
2020
Q2 | $16.4M | Sell |
343,989
-14,045
| -4% | -$670K | 0.13% | 126 |
|
|
2020
Q1 | $17.5M | Sell |
358,034
-10,630
| -3% | -$521K | 0.21% | 101 |
|
|
2019
Q4 | $21.2M | Buy |
+368,664
| New | +$21.2M | 0.22% | 99 |
|